Article
Rebamipide treatment ameliorates obesity phenotype by regulation of immune cells and adipocytes.
PloS one - 1 Jan 2022
Jhun JooYeon, Moon Jeonghyeon, Kim Se-Young, Cho Keun-Hyung, Na Hyun Sik, Choi JeongWon, Jung Yoon Ju, Song Kyo Young, Min Jun-Ki, Cho Mi-La
Abstract excerpt
Obesity is a medical term used to describe an over-accumulation of adipose tissue. It causes abnormal physiological and pathological processes in the body. Obesity is associated with systemic inflammation and abnormalities in immune cell function. Rebamipide, an amino acid derivative of 2-(1H)-quinolinone, has been used as a therapeutic for the protection from mucosal damage. Our previous studies have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
